U.S. Insurance Stock News

In March 2026, WeRide entered Slovakia through a partnership with ELEVATE Slovakia and public sector bodies to launch the country’s first autonomous vehicle program, deploying Robotaxis, Robobuses, Robovans and Robosweepers under the supervision of the Ministry of Transport. This move extends WeRide’s global reach into Central Europe and pairs its multi-product autonomous platform with a national initiative designed to build a regulatory-ready framework for fully driverless operations over...

In early March 2026, Bright Horizons Family Solutions Inc. announced a new share repurchase program of up to US$600 million, with all repurchased shares to be retired and no set expiration date. This move follows the completion of a prior buyback under which the company retired 3,970,538 shares for US$372.4 million, removing just over 7% of its share count and further concentrating future earnings among remaining shareholders. Next, we’ll examine how this expanded buyback, against the...

Earlier in March 2026, Marvell Technology, Inc. expanded its AI data center connectivity lineup by unveiling industry-first 260-lane PCIe 6.0 and CXL 3.0 switches, while also declaring a quarterly dividend of US$0.06 per share payable on April 30, 2026 to stockholders of record on April 10, 2026. By integrating high-radix PCIe and rack-level CXL memory pooling built on the XConn acquisition, Marvell is positioning its portfolio around end-to-end interconnect fabrics that aim to address AI...

Wondering if TechnipFMC at US$65.26 is still offering value after its strong run, or if most of the opportunity is already priced in. The stock has posted returns of 3.5% over the last 7 days, 2.8% over the last 30 days, 37.9% year to date and 123.4% over the past year, with a very large 3 year return and a roughly 7x 5 year return that naturally raises questions about risk and reward from here. Recent attention around TechnipFMC has centered on its role in energy services, contract wins and...

Regulatory and Clinical Updates Put Sarepta Therapeutics (SRPT) in Focus Sarepta Therapeutics (SRPT) has drawn fresh investor attention after receiving FDA feedback that supports supplemental applications for AMONDYS 45 and VYONDYS 53, alongside new enrollment activity in its ELEVIDYS ENDEAVOR Cohort 8 safety study. See our latest analysis for Sarepta Therapeutics. Despite the fresh FDA and clinical updates, Sarepta's recent share price performance has been weak, with a 1 month share price...

If you are wondering whether MercadoLibre's share price still reflects its long term potential or if the market has moved too far, the starting point is to look closely at what the current valuation is actually implying. The stock last closed at US$1,635.76, with returns of 2.1% decline over 7 days, 18.1% decline over 30 days, 17.1% decline year to date and 21.9% decline over 1 year, while the 3 year and 5 year returns stand at 37.8% and 14.2% respectively. Recent headlines around large...

Sterling Infrastructure, Inc. has already reported record Q3 2025 results, with performance driven by strong E-Infrastructure demand, margin expansion, and robust cash generation, prompting management to raise full-year guidance. The interesting angle is that profit growth is now expected to outpace revenue expansion, highlighting improving operational efficiency and mix within Sterling’s higher-value E-Infrastructure portfolio. Next, we’ll examine how record Q3 results and upgraded...

Earlier this month, Lincoln Financial Group introduced two new fixed indexed annuities, Lincoln FlexAdvantage Income and Lincoln OptiBlend Income, featuring guaranteed lifetime income, downside protection and an optional Estate Lock Death Benefit, while also rolling out a new FIA income calculator and enhanced digital servicing tools. At the same time, Lincoln National has reportedly been exploring a reinsurance deal that could move about US$5.00 billion of life insurance reserves off its...

Recent performance snapshot for Hershey (HSY) Hershey (HSY) has drawn attention after a recent share price pullback, with the stock down around 5% over the past month, while the past 3 months show a double digit gain. See our latest analysis for Hershey. For context, Hershey’s recent pullback sits against a stronger backdrop, with a 90 day share price return of 12.75% and a 1 year total shareholder return of 29.56%. This suggests momentum has cooled in the short term but remains positive over...

Wondering whether Equity Residential at around US$57.98 is a potential bargain or a value trap? This article focuses squarely on what you are getting for the price you see on screen. The stock has recently seen a 3.4% decline over the last 7 days and is down 7.4% over the last 30 days, with a 13.4% negative return over the last year but a 15.9% gain across the last 3 years. These price moves sit against a backdrop of ongoing interest in residential real estate investment trusts and changing...

G-III Apparel Group recently reported fourth-quarter and full-year results showing sales falling to US$771.49 million for the quarter and US$2.96 billion for the year, alongside a quarterly net loss of US$31.94 million and a new quarterly cash dividend of US$0.10 per share payable on March 30, 2026. Management linked the weaker profitability to the exit of Calvin Klein and Tommy Hilfiger licenses and a one-time bad debt expense tied to the Saks bankruptcy, underscoring how dependent past...

AeroVironment (AVAV) has drawn attention after a sharp pullback, with the stock showing a negative return over the past month and past 3 months. This has prompted investors to reassess expectations around its valuation. See our latest analysis for AeroVironment. The recent pullback sits against a much stronger longer term picture, with a 1 year total shareholder return of 58.16% and a 3 year total shareholder return of 119.54%. Short term share price momentum is clearly fading, while longer...

Why Cal-Maine Foods Is On Investors’ Radar Cal-Maine Foods (CALM) has drawn attention after recent share price moves, with the stock showing negative returns over the past week, month, and past 3 months. This performance is prompting investors to reassess the egg producer’s fundamentals. See our latest analysis for Cal-Maine Foods. The recent pullback, including a 10.81% 7 day share price decline to about $78.35, contrasts with Cal-Maine Foods’ much stronger 3 year and 5 year total...

Interest in Humacyte (HUMA) is being shaped by a US$1.475 million minimum purchase commitment for Symvess in Saudi Arabia, along with a Marketing Authorization Application in Israel, both focused on vascular trauma treatment. See our latest analysis for Humacyte. The recent Saudi Arabia purchase commitment and Israel filing come at a time when Humacyte's share price return has moved sharply, with a 7 day share price return of 32.51% and a 1 year total shareholder return of 76.42%, suggesting...

Meta Platforms (META) continues to attract attention as investors weigh its current share price of US$593.66 against the company’s recent performance, including a roughly 9% decline over the past month and a slightly negative 1 year total return. See our latest analysis for Meta Platforms. The recent 9.5% 1 month share price decline and softer year to date share price return sit in contrast to a very large 3 year total shareholder return. This suggests momentum has cooled after a strong multi...

Amazon.com (NasdaqGS:AMZN) is working on a new AI focused smartphone project, code named "Transformer", that aims to tightly link generative AI, Alexa, and Prime on mobile devices. The company is also investing in robotics through the Rivr acquisition and in climate related technology via a collaboration with Greentown Labs. These moves point to a broader push across smartphones, automation, and decarbonization partnerships that has not been widely discussed in recent coverage. For...

Baidu (NasdaqGS:BIDU) announced the resignation of Mr. James Ding as an independent director. Mr. Ding also stepped down as chairman of Baidu's compensation committee. The change affects the composition and leadership of Baidu's board-level oversight. Baidu operates as a major internet and AI company in China, with businesses that span search, online marketing and cloud services. For investors, board composition matters because it shapes how executive pay, risk controls and long term...

Long-serving director Kevin A. Lobo plans to step down from Parker-Hannifin's board after his election to the board of GE HealthCare Technologies. Lobo has served on Parker-Hannifin's board since 2013, and his departure represents a change in the governance lineup at NYSE:PH. Parker-Hannifin, trading on the NYSE under ticker NYSE:PH, comes into this board transition with a current share price of $894.41. The stock has returned 45.1% over the past year and has gains of 188.5% over the past 3...

Chubb (NYSE:CB) has been appointed lead underwriter for a U.S. government backed $20b maritime war risk insurance program focused on the Strait of Hormuz. The program is intended to support continued shipping activity in a region facing elevated geopolitical tensions. Chubb also named Seshadri Iyer as Executive Vice President for Operations, Technology, and Digital Transformation. For investors tracking NYSE:CB, these developments come with the stock at a share price of $322.58 and a 1-year...

CRA International (CRAI) has drawn fresh investor attention after reporting quarterly revenue growth of 11.6% year over year, surpassing analyst expectations. The company also set an eighth consecutive annual revenue record, with guidance coming in ahead of forecasts. See our latest analysis for CRA International. Despite the recent earnings beat, CRA International’s short-term share price returns remain weak, with a 30-day share price decline of 4.91% and a 90-day share price decline of...

Humana (HUM) has come onto investors’ radar after recent share price moves, with the stock showing a loss of around 35% over the past year despite reporting US$129.7b in revenue and US$1.2b in net income. See our latest analysis for Humana. Despite a 2.1% 1 day share price return and 2.7% 7 day share price return lifting the latest price to US$169.90, Humana’s 1 year total shareholder return of 35.3% and 3 year total shareholder return of 65.1% indicate pressure and fading momentum. If you...

Grupo Aeroméxico (NYSE:AERO) has filed a substantial shelf registration tied to an employee stock ownership plan. The registration relates to future issuance of shares to employees under the ESOP framework. The move signals a fresh phase in the company’s capital planning and workforce incentive approach. Grupo Aeroméxico, listed as NYSE:AERO, operates as Mexico’s flagship airline with a focus on passenger and cargo services. The new ESOP related shelf registration arrives at a time when...

CoreWeave (CRWV) is drawing attention after recent price swings, with a roughly 9% decline over the past month and a smaller fall over the past 3 months, despite modest gains over the past week. See our latest analysis for CoreWeave. The recent 1 day share price return of 1% to US$81.47 follows a 1 month share price return decline of 8.7% and a 3 month share price return decline of 4%, while the year to date share price return of 2.7% suggests momentum that has been choppy rather than one...

If you are wondering whether Pharvaris at around US$26 a share still offers value, it helps to step back and look at what the recent returns and current valuation are really telling you. The stock has delivered a 68.8% return over the past year and a very large 3 year gain of around 3.5x, even though the year to date return is a 1.8% decline and the 30 day return is a 7.5% decline. This can change how the risk and reward balance feels right now. Recent headlines around Pharvaris have focused...